Mark Ayers
Impact in
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 25
- Cancer Immunotherapy and Biomarkers 14
- Cancer-related Molecular Pathways 5
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 4
-
- Breast Cancer Treatment Studies 7
- Cancer Genomics and Diagnostics 4
- Co-authors
- Lajos Pusztai (16 shared papers)Jared K. Lunceford (12 shared papers)James Joseph Stec (14 shared papers)W. Fraser Symmans (12 shared papers)Sarina Anne Piha-Paul (3 shared papers)Andrey P. Loboda (9 shared papers)Jeffrey S. Ross (9 shared papers)Gabriel N. Hortobágyi (14 shared papers)
- Journals
- Annals of Oncology (6 papers)Clinical Cancer Research (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)Expert Review of Molecular Diagnostics (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Mark Ayers
42 papers receiving 11.8k citations
Mark Ayers's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 6.0k
- Cancer Research 3.0k
- Immunology 2.0k
- Pulmonary and Respiratory Medicine 2.6k
- Pathology and Forensic Medicine 942
Countries citing papers authored by Mark Ayers
This map shows the geographic impact of Mark Ayers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ayers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ayers more than expected).
Fields of papers citing papers by Mark Ayers
This network shows the impact of papers produced by Mark Ayers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ayers. The network helps show where Mark Ayers may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ayers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade Hit paper breakdown → | 2017 | 2910 |
| 2 | Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy Hit paper breakdown → | 2018 | 1795 |
| 3 | Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes Hit paper breakdown → | 2015 | 1736 |
| 4 | Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy Hit paper breakdown → | 2005 | 1519 |
| 5 | T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028 Hit paper breakdown → | 2018 | 761 |
| 6 | 2003 | 486 | |
| 7 | 2004 | 462 | |
| 8 | 2005 | 353 | |
| 9 | 2008 | 199 | |
| 10 | Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. | 2003 | 193 |
| 11 | 2003 | 152 | |
| 12 | 2019 | 89 | |
| 13 | 2019 | 86 | |
| 14 | 2019 | 86 | |
| 15 | 2003 | 85 | |
| 16 | 2002 | 85 | |
| 17 | 2016 | 83 | |
| 18 | 2015 | 80 | |
| 19 | 2022 | 76 | |
| 20 | 2019 | 73 |
About Mark Ayers
Mark Ayers is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 44 papers that have together received 12.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Breast Cancer Treatment Studies (7 papers), Cancer-related Molecular Pathways (5 papers), Cancer Genomics and Diagnostics (4 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Molecular Biology Techniques and Applications (3 papers) and Gene expression and cancer classification (3 papers). The work is most often cited by research in Oncology (6.0k citations), Cancer Research (3.0k citations), Immunology (2.0k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Pathology and Forensic Medicine (942 citations). Mark Ayers has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Lajos Pusztai, Jared K. Lunceford, James Joseph Stec, W. Fraser Symmans, Sarina Anne Piha-Paul, Andrey P. Loboda, Jeffrey S. Ross, Gabriel N. Hortobágyi, Michael Nebozhyn and Andrew V Albright. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Expert Review of Molecular Diagnostics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.